Invitek, part of the STRATEC group since 2009, have changed their name to STRATEC Molecular as part of their integration into the STRATEC group.
The company is a globally active provider of innovative solutions for nucleic acid sample collection, stabilization, and both manual and automated purification from any sample type. Since 1992 the company is internationally respected for its outstanding and high performance technology platforms and offers a broad spectrum of superior products for molecular diagnostics, drug discovery and Life Science research.
The Team
The highly motivated staff members of STRATEC Molecular are an interdisciplinary team, which is an integrated part of the Biomedical Research Campus in Berlin-Buch. The proximity to the Max-Delbrück-Center for Molecular Medicine (MDC), the Helios Clinics and more than 30 biotech companies allows collaboration in development and testing of solutions developed by the STRATEC Molecular team. The achievements and capabilities of the team are documented in over 40 patents in the United States and Europe and by numerous publications.
About STRATEC
STRATEC Biomedical Systems AG (www.stratec.com) designs and manufactures fully automated systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies.
The STRATEC Group consists of the publicly listed parent company STRATEC Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania.
The new STRATEC Molecular Universal kit series simplifies laboratory workflows by using one uniform protocol for purification of different nucleic acids from a variety of molecular diagnostic relevant...
The InviGenius provides advanced and reliable performance in automated nucleic acid sample preparation in combination with the well established magnetic bead based InviMag technology for DNA and RNA p...
Invitek, part of the STRATEC group since 2009, have changed their name to STRATEC Molecular as part of their integration into the STRATEC group.
The company is a globally active provider of innovative solutions for nucleic acid sample collection, stabilization, and both manual and automated purification from any sample type. Since 1992 the company is internationally respected for its outstanding and high performance technology platforms and offers a broad spectrum of superior products for molecular diagnostics, drug discovery and Life Science research.
The Team
The highly motivated staff members of STRATEC Molecular are an interdisciplinary team, which is an integrated part of the Biomedical Research Campus in Berlin-Buch. The proximity to the Max-Delbrück-Center for Molecular Medicine (MDC), the Helios Clinics and more than 30 biotech companies allows collaboration in development and testing of solutions developed by the STRATEC Molecular team. The achievements and capabilities of the team are documented in over 40 patents in the United States and Europe and by numerous publications.
About STRATEC
STRATEC Biomedical Systems AG (www.stratec.com) designs and manufactures fully automated systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies.
The STRATEC Group consists of the publicly listed parent company STRATEC Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania.
